Abstract
Adoptive therapy with antigen-specific T cells is a promising approach for the treatment of infectious diseases and cancer. However, cloning of antigen-specific T cells by the traditional approach of limiting dilution is a time-consuming, laborious, and inefficient process. Here, we describe a novel flow cytometric strategy for rapid isolation of human tumor antigen-specific T-cell clones by using T-cell receptor (TCR) Vβ antibodies in combination with carboxyfluorescein succinimidyl ester (CFSE)-based proliferation assay. The CFSE dilution following antigen stimulation identified proliferating antigen-specific T cells, and the TCRVβ antibodies allowed distinguishing T cells at the clonal level from a heterogeneous T-cell population. This method of TCRVβ/CFSE dilution was used for the isolation of four different human lymphoma and melanoma-specific CD4+ and CD8+ T-cell clones reactive against defined and undefined tumor antigens. Isolated tumor-specific T-cell clones could be expanded to large numbers ex vivo while maintaining phenotype, function, and tumor antigen specificity. The method was simple, efficient, and reproducible, and may have potential application for the development of adoptive immunotherapeutic strategies.
Original language | English (US) |
---|---|
Pages (from-to) | 13-26 |
Number of pages | 14 |
Journal | Journal of Immunological Methods |
Volume | 331 |
Issue number | 1-2 |
DOIs | |
State | Published - Feb 29 2008 |
Keywords
- Cloning
- Human
- T cells
- TCR
- Tumor
- Vbeta
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
MD Anderson CCSG core facilities
- Flow Cytometry and Cellular Imaging Facility